Screening for biomarkers of liver injury induced by Polygonum multiflorum: a targeted metabolomic st

来源 :2016何首乌及其制剂临床价值与精准用药高级研讨会 | 被引量 : 0次 | 上传用户:wellstudyc
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Heshouwu (HSW), the dry roots of Polygonum multiflorum, a classical traditional Chinese medicine is used as a tonic for a wide range of conditions, particularly those associated with aging.However, it tends to be taken overdose or long term in these years, which has resulted in liver damage reported in many countries.In this study, the indicative roles of nine bile acids (BAs) were evaluated to offer potential biomarkers for HSW induced liver injury.Nine BAs including cholic acid (CA) and chenodeoxycholic acid (CDCA), taurocholic acid (TCA), glycocholic acid (GCA),glycochenodeoxycholic acid (GCDCA), deoxycholic acid (DCA), glycodeoxycholic acid (GDCA),ursodeoxycholic acid (UDCA) and hyodeoxycholic acid (HDCA) in rat bile and serum were detected by a developed LC-MS method after 42 days treatment.Partial least square-discriminate analysis (PLS-DA) was applied to evaluate the indicative roles of the nine BAs, and metabolism of the nine BAs was summarized.Significant change was observed for the concentrations of nine BAs in treatment groups compared with normal control;In the PLS-DA plots of nine BAs in bile, normal control and raw HSW groups were separately clustered and could be clearly distinguished, GDCA was selected as the distinguished components for raw HSW overdose treatment group.In the PLS-DA plots of nine BAs in serum, the normal control and raw HSW overdose treatment group were separately clustered and could be clearly distinguished, and HDCA was selected as the distinguished components for raw HSW overdose treatment group.The results indicated the perturbation of nine BAs was associated with HSW induced liver injury;GDCA in bile, as well as HDCA in serum could be selected as potential biomarkers for HSW induced liver injury;it also laid the foundation for the further search on the mechanisms of liver injury induced by HSW.
其他文献
目的:检测何首乌对人肝细胞(LO2)的毒性和细胞凋亡的影响.方法:通过细胞形态分析、流式细胞术考察何首乌及其三个单体成分对肝细胞凋亡的影响.结果:与空白对照组相比,何首乌70%乙醇提取物(1、2、4mg生药/mL)对肝细胞形态和细胞周期影响均不明显,给药24h凋亡率为9.51、10.3、13.2%;何首乌中三个成分大黄素、大黄酸和没食子酸单独给药(25、50、100μmol/L),各给药组细胞均可
目的:观察大剂量何首乌对大鼠主要脏器的损伤作用,暴露其可能的毒性作用.方法:采用亚急性毒性试验,初步比较生何首乌和制何首乌不同提取物(20g生药/kg)灌胃28天的毒性,观察肝脏病变频数;进一步对毒性较大的生何首乌和制何首乌醇提物进行研究,以40g生药/kg连续灌胃28天,观察大鼠体重增长情况、脏器指数变化、肝肾功能生化指标、组织病变结果.结果:初步发现生何首乌和制何首乌醇提物毒性均大于各自的水提
何首乌是蓼科植物何首乌Polygonum multiflorum Thunb.的干燥块根,其作为传统补益药临床应用广泛,已有逾千年的用药历史.近年来在许多国家关于何首乌大剂量、长期使用导致肝损伤的报道逐渐增多.课题组前期研究显示胆汁酸代谢在何首乌药物肝损伤中受到一定程度的影响,本研究通过靶向代谢组学研究9个主要胆汁酸在胆汁及血清中的水平以筛选何首乌药物性肝损伤潜在生物标志物.大鼠给药42天后,检测
基于内毒素特异质肝损伤模型,考察何首乌对大鼠肝脏的损伤作用.将何首乌(Polygonum multiflorum Thunb.)50%乙醇提取物单独灌胃或联合无毒剂量的脂多糖(lipopolysaccharide,LPS,尾静脉注射2.8mg/kg)给药SD大鼠,检测血清丙氨酸氨基转氨酶(ALT)、天冬氨酸氨基转氨酶(AST),HE染色观察肝脏病理学改变,对比考察何首乌单用或联合LPS的量-毒关系
汤剂是中药临床最常使用的剂型之一,汤剂中化学成分的稳定性关乎临床药效与安全性.有关汤剂用水中金属离子对中药成分稳定性影响的研究报道较少,汤剂用水是否要控制金属离子也缺少科学依据支持.本文以何首乌中主要成分二苯乙烯苷(2,3,5,4-tetrahydroxy stilbene-2-0-β-D-glucoside,THSG)为例,比较研究了普通自来水、去离子水以及含不同浓度金属离子水对THSG稳定性影
目的:近年来首乌肝中毒事件频发,针对网购制首乌大量增加及质量监测缺失的问题,检测不同批次网购制首乌质量和肝细胞毒性大小,并比较首乌不同炮制工艺的减毒效果,为规范和提高何首乌临床用药的安全性提供参考.方法:采用指标成分定量测定、化学指纹图谱和肝细胞毒性评价,考察网购制首乌质量差异;比较不同炮制方法对首乌肝细胞毒性降低效果.结果:网购的26批制首乌二苯乙烯苷在0.004%~3.442%,其中有8批不符
目的:建立HPLC法测定慢肝宁胶囊中何首乌所合大黄素的含量测定方法.方法:采用高效液相色谱法,使用C18柱,流动相为乙腈-水-冰醋酸(60∶40∶1)为流动相,流速1.0ml/min,检测波长437nm,进样量20ul.结果:本方法能准确测定方中何乌首所含大黄素的含量,线性关系良好,加样回收率98.7%,符合分析的需要.结论:方法简单、准确、快速,能有效控制该制剂质量.
目的:分析何首乌肝毒性的客观真实性与何首乌及其制剂导致药物性肝损伤(drug-inducedliverinjury,DILI)的临床特征.方法:回顾性分析2009年1月-2014年1月解放军第三○二医院收治的158例发病前有何首乌及其制剂应用史DILI患者的临床特征及治疗预后等临床资料.结果:158例发病前有何首乌及其制剂应用史的DILI患者中,92例(58.2%)与西药或不含何首乌中药制剂联合应
本研究采用正常和CCl4致慢性肝损伤模型大鼠,何首乌给药剂量分别为生药10和20g·kg-1,考察何首乌50%醇提物对大鼠的一般状态、生化指标、细胞因子及组织病理的影响,并通过因子分析方法综合评价不同剂量何首乌在不同大鼠模型上的量-效/毒应答差异.结果显示,与正常对照组相比,正常高剂量组ALT(谷丙转氨酶)、TBIL(总胆红素)、HMGB-1(高迁移率族蛋白1)、IL-1β(白细胞介素-1β)显著
会议